Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Szalai, Gabor ^a   Romero, Roberto ^a   Chaiworapongsa, Tinnakorn ^a,b   Xu, Yi ^a   Wang, Bing ^a   Ahn, Hyunyoung ^a   Xu, Zhonghui ^a   Chiang, Po Jen ^a   Sundell, Birgitta ^a   Wang, Rona ^a   Jiang, Yang ^a   Plazyo, Olesya ^a   Olive, Mary ^a,b   Tarca, Adi L ^a,b,c   Dong, Zhong ^a   Qureshi, Faisal ^b   Papp, Zoltan ^d   Hassan, Sonia S ^a,b   Hernandez Andrade, Edgar ^a,b   Than, Nandor Gabor ^a,b,d,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Wayne State University   (United States)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FMS LIKE TYROSINE KINASE 1 E15A ISOFORM; UNCLASSIFIED DRUG; FLT1 PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; ISOPROTEIN; MESSENGER RNA; RECOMBINANT PROTEIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CAPILLARY ENDOTHELIAL CELL; CELL SWELLING; CESAREAN SECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; FETUS WEIGHT; GLOMERULUS CAPILLARY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; KIDNEY INJURY; LIVER DISEASE; MICROALBUMINURIA; MOUSE; NONHUMAN; PHENOTYPE; PLACENTA WEIGHT; PREECLAMPSIA; PROTEIN EXPRESSION; PUERPERIUM; SURVIVAL; SURVIVAL RATE; AMINO ACID SEQUENCE; ANIMAL; BLOOD PRESSURE; BLOOD PRESSURE MONITOR; DIAGNOSTIC IMAGING; DISEASE MODEL; ECHOGRAPHY; GENE EXPRESSION PROFILING; GENETICS; GESTATIONAL AGE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TELEMETRY; TRANSGENIC MOUSE;

MUS; PRIMATES; RODENTIA;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE MONITORS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GESTATIONAL AGE; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHENOTYPE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; TELEMETRY; ULTRASONOGRAPHY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84928911040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119547     Document Type: Article

References (281)

1. Romero R. Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med. 2009; 22: 636-639. doi: 10.1080/14767050902784171 PMID: 19736614
2. Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med. 2009; 22: 633-635. doi: 10.1080/14767050902866804 PMID: 19736613
3. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990; 163: 460-465. PMID: 2386132
4. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183: S1-S22. PMID: 10944363
5. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001; 97: 533-538. PMID: 11275024
6. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003; 102: 181-192. PMID: 12850627
7. WHO. The world health report 2005: make every mother and child count. Geneva: WHO; 2005.
8. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365: 785-799. PMID: 15733721
9. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367: 1066-1074. PMID: 16581405
10. Than NG, Vaisbuch E, Kim CJ, Mazaki-Tovi S, Erez O, Yeo L, et al. Early-onset preeclampsia and HELLP syndrome: an overview. In: Preedy VR, editor. Handbook of Growth and Growth Monitoring in Health and Disease: Springer; 2012. pp. 1867-1891.
11. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010; 376: 631-644. doi: 10.1016/S0140-6736(10)60279-6 PMID: 20598363
12. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22: 143-148. PMID: 12908998
13. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta. 2007; 28: 487-497. PMID: 16860862
14. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008; 52: 873-880. doi: 10.1161/HYPERTENSIONAHA.108.117358 PMID: 18824660
15. Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol. 2006; 30: 16-19. PMID: 16549208
16. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 391-403. doi: 10.1016/j.bpobgyn.2011.01.006 PMID: 21333604
17. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004; 190: 1464-1466. PMID: 15167870
18. von Dadelszen P, Menzies JM, Payne B, Magee LA. Predicting adverse outcomes in women with severe pre-eclampsia. Semin Perinatol. 2009; 33: 152-157. doi: 10.1053/j.semperi.2009.02.009 PMID: 19464505
19. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011; 66: 497-506. doi: 10.1097/OGX.0b013e3182331028 PMID: 22018452
20. Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. Br J Obstet Gynaecol. 1980; 87: 13-18. PMID: 7362784
21. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982; 142: 159-167. PMID: 7055180
22. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996; 175: 1365-1370. PMID: 8942516
23. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997; 177: 1003-1010. PMID: 9396883
24. Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J Perinat Med. 2000; 28: 249-260. PMID: 11031696
25. Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta. 2002; 23: 359-372. PMID: 12061851
26. Baxter JK, Weinstein L. HELLP syndrome: the state of the art. Obstet Gynecol Surv. 2004; 59: 838-845. PMID: 15572962
27. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004; 31: 807-833, vii. PMID: 15519429
28. Noris M, Perico N, Remuzzi G. Mechanisms of disease: Pre-eclampsia. Nat Clin Pract Nephrol. 2005; 1: 98-114; quiz 120. PMID: 16932375
29. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009; 9: 8. doi: 10.1186/1471-2393-9-8 PMID: 19245695
30. Kim CJ, Romero R, Kusanovic JP, Yoo W, Dong Z, Topping V, et al. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol. 2010; 23: 1000-1011. doi: 10.1038/modpathol.2010.73 PMID: 20348884
31. Hernandez-Andrade E, Serralde JA, Cruz-Martinez R. Can anomalies of fetal brain circulation be useful in the management of growth restricted fetuses? Prenat Diagn. 2012; 32: 103-112. doi: 10.1002/pd.2913 PMID: 22418951
32. Hernandez-Andrade E, Stampalija T, Figueras F. Cerebral blood flow studies in the diagnosis and management of intrauterine growth restriction. Curr Opin Obstet Gynecol. 2013; 25: 138-144. doi: 10.1097/GCO.0b013e32835e0e9c PMID: 23354073
33. Page EW. Placental dysfunction in eclamptogenic toxemias. Obstet Gynecol Surv. 1948; 3: 615-628. PMID: 18886472
34. Page EW. The physiologic basis of symptoms in eclampsia. Calif Med. 1949; 70: 1-4. PMID: 18104713
35. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta. 1991; 12: 301-308. PMID: 1946241
36. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta. 2003; 24 Suppl A: S21-27. PMID: 12842410
37. Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010; 5: 173-192. doi: 10.1146/annurev-pathol-121808-102149 PMID: 20078220
38. Eastabrook G, Brown M, Sargent I. The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 435-447. doi: 10.1016/j.bpobgyn.2011.01.005 PMID: 21367667
39. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol. 1967; 93: 581-592. PMID: 6054058
40. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977; 4: 573-593. PMID: 598186
41. Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol. 1981; 88: 876-881. PMID: 7272259
42. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986; 93: 1049-1059. PMID: 3790464
43. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997; 99: 2152-2164. PMID: 9151787
44. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003; 69: 1-7. PMID: 12620937
45. Espinoza J, Romero R, Mee Kim Y, Kusanovic JP, Hassan S, Erez O, et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med. 2006; 34: 447-458. PMID: 17140293
46. Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010; 25: 569-574. doi: 10.1093/humrep/dep474 PMID: 20085913
47. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011; 204: 193-201. doi: 10.1016/j.ajog.2010.08.009 PMID: 21094932
48. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007; 196: 261 e261-266. PMID: 17346547
49. Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch. 2008; 453: 387-400. doi: 10.1007/s00428-008-0658-x PMID: 18791734
50. Singh H, Makino SI, Endo Y, Nie G. Inhibition of HTRA3 stimulates trophoblast invasion during human placental development. Placenta. 2010; 31: 1085-1092. doi: 10.1016/j.placenta.2010.10.003 PMID: 21035848
51. Varkonyi T, Nagy B, Fule T, Tarca AL, Karaszi K, Schonleber J, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011; 32 Suppl: S21-29. doi: 10.1016/j.placenta.2010.04.014 PMID: 20541258
52. Li Y, Puryer M, Lin E, Hale K, Salamonsen LA, Manuelpillai U, et al. Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia. J Clin Endocrinol Metab. 2011; 96: 403-411. doi: 10.1210/jc.2010-1405 PMID: 21047919
53. Singh H, Endo Y, Nie G. Decidual HtrA3 negatively regulates trophoblast invasion during human placentation. Hum Reprod. 2011; 26: 748-757. doi: 10.1093/humrep/der019 PMID: 21321049
54. Kliman HJ, Sammar M, Grimpel YI, Lynch SK, Milano KM, Pick E, et al. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia. Reprod Sci. 2012; 19: 16-30. doi: 10.1177/1933719111424445 PMID: 21989657
55. Dynon K, Heng S, Puryer M, Li Y, Walton K, Endo Y, et al. HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening. PLoS One. 2012; 7: e45956. doi: 10.1371/journal.pone.0045956 PMID: 23049902
56. Than NG, Romero R, Xu Y, Erez O, Xu Z, Bhatti G, et al. Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta. 2014; 35: 855-865. doi: 10.1016/j.placenta.2014.07.015 PMID: 25266889
57. Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR, et al. Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol. 2005; 193: 921-927. PMID: 16157088
58. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. Immunology of preeclampsia. Chem Immunol Allergy. 2005; 89: 49-61. PMID: 16129952
59. Kim JS, Romero R, Cushenberry E, Kim YM, Erez O, Nien JK, et al. Distribution of CD14+ and CD68+ macrophages in the placental bed and basal plate of women with preeclampsia and preterm labor. Placenta. 2007; 28: 571-576. PMID: 17052752
60. Dekker G, Robillard PY. Pre-eclampsia: Is the immune maladaptation hypothesis still standing? An epidemiological update. J Reprod Immunol. 2007; 76: 8-16. PMID: 17493684
61. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010; 63: 534-543. doi: 10.1111/j.1600-0897.2010.00831.x PMID: 20331588
62. Burke SD, Barrette VF, Gravel J, Carter AL, Hatta K, Zhang J, et al. Uterine NK cells, spiral artery modification and the regulation of blood pressure during mouse pregnancy. Am J Reprod Immunol. 2010; 63: 472-481. doi: 10.1111/j.1600-0897.2010.00818.x PMID: 20175772
63. Leno-Duran E, Hatta K, Bianco J, Yamada AT, Ruiz-Ruiz C, Olivares EG, et al. Fetal-placental hypoxia does not result from failure of spiral arterial modification in mice. Placenta. 2010; 31: 731-737. doi: 10.1016/j.placenta.2010.06.002 PMID: 20580083
64. Girardi G, Prohaszka Z, Bulla R, Tedesco F, Scherjon S. Complement activation in animal and human pregnancies as a model for immunological recognition. Mol Immunol. 2011; 48: 1621-1630. doi: 10.1016/j.molimm.2011.04.011 PMID: 21600656
65. Webster RP, Roberts VH, Myatt L. Protein nitration in placenta-functional significance. Placenta. 2008; 29: 985-994. doi: 10.1016/j.placenta.2008.09.003 PMID: 18851882
66. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009; 30: 473-482. doi: 10.1016/j.placenta.2009.02.009 PMID: 19375795
67. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta. 2009; 30 Suppl A: S43-48. doi: 10.1016/j.placenta.2008.11.003 PMID: 19081132
68. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009; 7: 375-384. doi: 10.1111/j.1538-7836.2008.03259.x PMID: 19087223
69. Romero R, Kusanovic JP, Chaiworapongsa T, Hassan SS. Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 313-327. doi: 10.1016/j.bpobgyn.2011.02.006 PMID: 21388889
70. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003; 24: 219-226. PMID: 12566249
71. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol. 2003; 189: 1173-1177. PMID: 14586374
72. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol. 2003; 101: 575-583. PMID: 12636965
73. Sebire NJ, Goldin RD, Regan L. Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol. 2005; 25: 117-118. PMID: 15814385
74. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011; 39: 641-652. doi: 10.1515/JPM.2011.098 PMID: 21848483
75. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350: 672-683. PMID: 14764923
76. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 2005; 48: 372-386. PMID: 15805796
77. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 308: 1592-1594. PMID: 15947178
78. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006; 11: 309-316. PMID: 16828580
79. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract. 2007; 106: c72-81. PMID: 17570933
80. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008; 59: 61-78. PMID: 17937587
81. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30 Suppl A: S38-42. doi: 10.1016/j.placenta.2008.11.021 PMID: 19138798
82. Kalkunte S, Lai Z, Norris WE, Pietras LA, Tewari N, Boij R, et al. Novel approaches for mechanistic understanding and predicting preeclampsia. J Reprod Immunol. 2009; 83: 134-138. doi: 10.1016/j.jri.2009.08.006 PMID: 19836839
83. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009; 30 Suppl A: S32-37. doi: 10.1016/j.placenta.2008.11.009 PMID: 19070896
84. Sharma S, Norris WE, Kalkunte S. Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia. J Reprod Immunol. 2010; 85: 112-116. doi: 10.1016/j.jri.2010.01.002 PMID: 20236707
85. Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, et al. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol. 2010; 177: 2387-2398. doi: 10.2353/ajpath.2010.100475 PMID: 20889559
86. Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011; 31: 33-46. doi: 10.1016/j.semnephrol.2010.10.004 PMID: 21266263
87. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111: 649-658. PMID: 12618519
88. Bdolah Y, Karumanchi SA, Sachs BP. Recent advances in understanding of preeclampsia. Croat Med J. 2005; 46: 728-736. PMID: 16158464
89. Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005; 57: 1R-7R. PMID: 15817508
90. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12: 642-649. PMID: 16751767
91. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009; 24: 147-158. doi: 10.1152/physiol.00043.2008 PMID: 19509125
92. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol. 2003; 59: 153-160. PMID: 12896819
93. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007; 178: 5949-5956. PMID: 17442979
94. Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, Yagel S, et al. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res. 2008; 102: 1566-1574. doi: 10.1161/CIRCRESAHA.108.171504 PMID: 18515749
95. Balogh A, Pozsgay J, Matko J, Dong Z, Kim CJ, Varkonyi T, et al. Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. Am J Obstet Gynecol. 2011; 205: 156 e151-114.
96. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000; 21: 597-602. PMID: 10985960
97. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001; 185: 792-797. PMID: 11641653
98. Chaiworapongsa T, Gervasi MT, Refuerzo J, Espinoza J, Yoshimatsu J, Berman S, et al. Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. Am J Obstet Gynecol. 2002; 187: 889-893. PMID: 12388971
99. Than NG, Romero R, Erez O, Kusanovic JP, Tarca AL, Edwin SS, et al. A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. Am J Reprod Immunol. 2008; 60: 333-345. doi: 10.1111/j.1600-0897.2008.00631.x PMID: 18727690
100. Ogge G, Romero R, Chaiworapongsa T, Gervasi MT, Pacora P, Erez O, et al. Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med. 2010; 23: 476-487. doi: 10.3109/14767050903216033 PMID: 19916874
101. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161: 1200-1204. PMID: 2589440
102. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol. 1993; 169: 160-165. PMID: 8333445
103. Higgins JR, Papayianni A, Brady HR, Darling MR, Walshe JJ. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol. 1998; 179: 464-469. PMID: 9731854
104. Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998; 16: 17-31. PMID: 9654604
105. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999; 180: 499-506. PMID: 9988826
106. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005; 67: 2101-2113. PMID: 15882253
107. Karumanchi SA, Lindheimer MD. Preeclampsia and the kidney: footprints in the urine. Am J Obstet Gynecol. 2007; 196: 287-288. PMID: 17403396
108. Erez O, Romero R, Kim SS, Kim JS, Kim YM, Wildman DE, et al. Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation. J Matern Fetal Neonatal Med. 2008; 21: 345-355. doi: 10.1080/14767050802034859 PMID: 18570113
109. Erez O, Romero R, Hoppensteadt D, Than NG, Fareed J, Mazaki-Tovi S, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med. 2008; 21: 855-869. doi: 10.1080/14767050802361872 PMID: 19065458
110. Erez O, Romero R, Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, Chaiworapongsa T, et al. Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death. J Matern Fetal Neonatal Med. 2009; 22: 662-671. doi: 10.1080/14767050902801751 PMID: 19591071
111. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 1999; 106: 1019-1022. PMID: 10519425
112. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004; 190: 1541-1547; discussion 1547-1550. PMID: 15284729
113. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005; 18: 9-16. PMID: 16105786
114. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of preeclampsia. J Matern Fetal Neonatal Med. 2005; 17: 3-18. PMID: 15804781
115. Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension. 2005; 46: 1077-1085. PMID: 16230516
116. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355: 992-1005. PMID: 16957146
117. Gotsch F, Romero R, Friel L, Kusanovic JP, Espinoza J, Erez O, et al. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med. 2007; 20: 777-792. PMID: 17943641
118. Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol. 2007; 197: 176 e171-176. PMID: 17689641
119. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol. 2007; 196: 239 e231-236. PMID: 17346536
120. Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, et al. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med. 2008; 21: 25-40. doi: 10.1080/14767050701832833 PMID: 18175242
121. Chaiworapongsa T, Romero R, Gotsch F, Espinoza J, Nien JK, Goncalves L, et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med. 2008; 21: 41-52. doi: 10.1080/14767050701831397 PMID: 18175243
122. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008; 21: 279-287. doi: 10.1080/14767050802034545 PMID: 18446652
123. Gotsch F, Romero R, Kusanovic JP, Chaiworapongsa T, Dombrowski M, Erez O, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med. 2008; 21: 389-402. doi: 10.1080/14767050802046069 PMID: 18570117
124. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008; 21: 9-23. doi: 10.1080/14767050701830480 PMID: 18175241
125. Than NG, Romero R, Hillermann R, Cozzi V, Nie G, Huppertz B. Prediction of preeclampsia - a workshop report. Placenta. 2008; 29 Suppl A: S83-85. PMID: 18061661
126. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009; 22: 1021-1038. doi: 10.3109/14767050902994754 PMID: 19900040
127. Chaiworapongsa T, Romero R, Kusanovic JP, Mittal P, Kim SK, Gotsch F, et al. Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations. Ultrasound Obstet Gynecol. 2010; 35: 155-162. doi: 10.1002/uog.7491 PMID: 20101637
128. Chaiworapongsa T, Romero R, Tarca AL, Kusanovic JP, Gotsch F, Mittal P, et al. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia. Am J Obstet Gynecol. 2010; 202: 550 e551-510.
129. Ogge G, Romero R, Kusanovic JP, Chaiworapongsa T, Dong Z, Mittal P, et al. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice. J Matern Fetal Neonatal Med. 2010; 23: 820-827. doi: 10.3109/14767050903366119 PMID: 20158394
130. Ahmed A. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb Res. 2011; 127 Suppl 3: S72-75. doi: 10.1016/S0049-3848(11)70020-2 PMID: 21262447
131. Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011; 24: 1187-1207. doi: 10.3109/14767058.2011.589932 PMID: 21827221
132. Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol. 2011; 204: 152 e151-159. doi: 10.1016/j.ajog.2010.08.049 PMID: 21062661
133. Eshkoli T, Holcberg G, Bronfenmacher B, Amash A, Huleihel M, Erez O. Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia. J Matern Fetal Neonatal Med. 2012; 26: 116-122. doi: 10.3109/14767058.2012.722725 PMID: 22928533
134. Moore AG, Young H, Keller JM, Ojo LR, Yan J, Simas TA, et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J Matern Fetal Neonatal Med. 2012; 25: 2651-2657. doi: 10.3109/14767058.2012.713055 PMID: 22861812
135. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012; 125: 911-919. doi: 10.1161/CIRCULATIONAHA.111.054361 PMID: 22261192
136. Reimer T, Rohrmann H, Stubert J, Pecks U, Glocker MO, Richter DU, et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J Matern Fetal Neonatal Med. 2012.
137. Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of preeclampsia. Clin Sci (Lond). 2012; 122: 43-52. doi: 10.1042/CS20110097 PMID: 21929511
138. Weed S, Bastek JA, Anton L, Elovitz MA, Parry S, Srinivas SK. Examining the correlation between placental and serum placenta growth factor in preeclampsia. Am J Obstet Gynecol. 2012; 207: 140 e141-146.
139. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998; 59: 1540-1548. PMID: 9828203
140. Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, Halmesmaki E. Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol. 2000; 95: 353-357. PMID: 10711543
141. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 2003; 88: 2348-2351. PMID: 12727995
142. Wang H, Li Q, Lin H, Yu X, Qian D, Dai J, et al. Expression of vascular endothelial growth factor and its receptors in the rhesus monkey (Macaca mulatta) endometrium and placenta during early pregnancy. Mol Reprod Dev. 2003; 65: 123-131. PMID: 12704722
143. Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem. 2004; 50: 1702-1703. PMID: 15331514
144. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 2004; 89: 770-775. PMID: 14764795
145. Berkane N, Lefevre G, Hertig A. Angiogenic factors in preeclampsia: so complex, so simple? Nephrol Dial Transplant. 2007; 22: 2753-2756. PMID: 17617654
146. Hertig A, Lefevre G, Toumi K, Rondeau E, Capeau J, Uzan S, et al. Soluble endoglin levels during normotensive and hypertensive pregnancies. Eur J Obstet Gynecol Reprod Biol. 2008; 140: 138-140. PMID: 17964708
147. Smith GC, Wear H. The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol. 2009; 21: 111-116. doi: 10.1097/GCO.0b013e328328cf7d PMID: 19996864
148. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010; 5: e13263. doi: 10.1371/journal.pone.0013263 PMID: 20948996
149. Hertig A, Fort J, Lefevre G, Chabbert-Buffet N, Uzan M, Rondeau E, et al. Soluble endoglin in preeclamptic patients with or without HELLP syndrome. Am J Obstet Gynecol. 2010; 202: 594 e591-594. doi: 10.1016/j.ajog.2010.03.006 PMID: 20430360
150. Muttukrishna S, Swer M, Suri S, Jamil A, Calleja-Agius J, Gangooly S, et al. Soluble Flt-1 and PlGF: new markers of early pregnancy loss? PLoS One. 2011; 6: e18041. doi: 10.1371/journal.pone.0018041 PMID: 21448460
151. Szalai G, Xu Y, Romero R, Chaiworapongsa T, Xu Z, Chiang PJ, et al. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy. PLoS One. 2014; 9: e110867. doi: 10.1371/journal.pone.0110867 PMID: 25393290
152. Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest. 2014; 124: 4941-4952. doi: 10.1172/JCI76864 PMID: 25329693
153. Heydarian M, McCaffrey T, Florea L, Yang Z, Ross MM, Zhou W, et al. Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta. 2009; 30: 250-255. doi: 10.1016/j.placenta.2008.12.010 PMID: 19147226
154. Jebbink J, Keijser R, Veenboer G, van der Post J, Ris-Stalpers C, Afink G. Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth. Hypertension. 2011; 58: 70-76. doi: 10.1161/HYPERTENSIONAHA.110.164079 PMID: 21518965
155. Whitehead CL, Palmer KR, Nilsson U, Gao Y, Saglam B, Lappas M, et al. Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia. BJOG. 2011; 118: 1268-1271. doi: 10.1111/j.1471-0528.2011.02962.x PMID: 21585639
156. Stout C, Lemmon WB. Glomerular capillary endothelial swelling in a pregnant chimpanzee. Am J Obstet Gynecol. 1969; 105: 212-215. PMID: 5817843
157. Baird JN Jr. Eclampsia in a lowland gorilla. Am J Obstet Gynecol. 1981; 141: 345-346. PMID: 7282812
158. Thornton JG, Onwude JL. Convulsions in pregnancy in related gorillas. Am J Obstet Gynecol. 1992; 167: 240-241. PMID: 1442933
159. Carter AM, Pijnenborg R. Evolution of invasive placentation with special reference to non-human primates. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 249-257. doi: 10.1016/j.bpobgyn.2010.10.010 PMID: 21056010
160. Terio KA, Kinsel MJ, Raphael J, Mlengeya T, Lipende I, Kirchhoff CA, et al. Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010. J Zoo Wildl Med. 2011; 42: 597-607. PMID: 22204054
161. Williams JM, Lonsdorf EV, Wilson ML, Schumacher-Stankey J, Goodall J, Pusey AE. Causes of death in the Kasekela chimpanzees of Gombe National Park, Tanzania. Am J Primatol. 2008; 70: 766-777. doi: 10.1002/ajp.20573 PMID: 18506732
162. Wildman DE, Uddin M, Romero R, Gonzalez JM, Than NG, Murphy J, et al. Spontaneous abortion and preterm labor and delivery in nonhuman primates: evidence from a captive colony of chimpanzees (Pan troglodytes). PLoS One. 2011; 6: e24509. doi: 10.1371/journal.pone.0024509 PMID: 21949724
163. Than NG. PP13, decidual zones of necrosis, and spiral artery remodeling-preeclampsia revisited?Reprod Sci. 2012; 19: 14-15. doi: 10.1177/1933719111431678 PMID: 22228738
164. McGowen MR, Erez O, Romero R, Wildman DE. The evolution of embryo implantation. Int J Dev Biol. 2014; 58: 155-161. doi: 10.1387/ijdb.140020dw PMID: 25023681
165. McCarthy FP, Kingdom JC, Kenny LC, Walsh SK. Animal models of preeclampsia; uses and limitations. Placenta. 2011; 32: 413-419. doi: 10.1016/j.placenta.2011.03.010 PMID: 21497901
166. Sunderland N, Hennessy A, Makris A. Animal models of pre-eclampsia. Am J Reprod Immunol. 2011; 65: 533-541. doi: 10.1111/j.1600-0897.2010.00929.x PMID: 21134030
167. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension. 2002; 39: 337-342. PMID: 11882569
168. Woods AK, Hoffmann DS, Weydert CJ, Butler SD, Zhou Y, Sharma RV, et al. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension. 2011; 57: 94-102. doi: 10.1161/HYPERTENSIONAHA.110.160242 PMID: 21079047
169. Hodari AA. Chronic uterine ischemia and reversible experimental "toxemia of pregnancy". Am J Obstet Gynecol. 1967; 97: 597-607. PMID: 6018981
170. Cavanagh D, Rao PS, Tsai CC, O'Connor TC. Experimental toxemia in the pregnant primate. Am J Obstet Gynecol. 1977; 128: 75-85. PMID: 403766
171. Clark KE, Durnwald M, Austin JE. A model for studying chronic reduction in uterine blood flow in pregnant sheep. Am J Physiol. 1982; 242: H297-301. PMID: 7065164
172. Losonczy G, Brown G, Venuto RC. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am J Med Sci. 1992; 303: 233-240. PMID: 1562040
173. Combs CA, Katz MA, Kitzmiller JL, Brescia RJ. Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol. 1993; 169: 215-223. PMID: 8333460
174. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension. 2005; 46: 1022-1025. PMID: 16144982
175. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, et al. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 2006; 122: 383-392. PMID: 16511995
176. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007; 50: 1142-1147. PMID: 17923588
177. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007; 71: 977-984. PMID: 17377512
178. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol. 2007; 293: H2080-2084. PMID: 17644567
179. Gilbert JS, Gilbert SA, Arany M, Granger JP. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension. 2009; 53: 399-403. doi: 10.1161/HYPERTENSIONAHA.108.123513 PMID: 19075097
180. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol. 2012; 303: H1-8. doi: 10.1152/ajpheart.00117.2012 PMID: 22523250
181. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994; 170: 1458-1466. PMID: 7909994
182. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995; 377: 239-242. PMID: 7545787
183. Salas SP, Altermatt F, Campos M, Giacaman A, Rosso P. Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension. 1995; 26: 1019-1023. PMID: 7498960
184. Shesely EG, Gilbert C, Granderson G, Carretero CD, Carretero OA, Beierwaltes WH. Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. Am J Obstet Gynecol. 2001; 185: 1198-1203. PMID: 11717657
185. Podjarny E, Bernheim J, Katz B, Green J, Mekler J, Bursztyn M. Chronic exogenous hyperinsulinemia in pregnancy: a rat model of pregnancy-induced hypertension. J Am Soc Nephrol. 1998; 9: 9-13. PMID: 9440081
186. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature. 2008; 453: 1117-1121. doi: 10.1038/nature06951 PMID: 18469803
187. Falcao S, Bisotto S, Gutkowska J, Lavoie JL. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake. Am J Obstet Gynecol. 2009; 200: 198 e191-195. doi: 10.1016/j.ajog.2008.10.003 PMID: 19110222
188. Doridot L, Chatre L, Ducat A, Vilotte JL, Lombes A, Mehats C, et al. Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene. Antioxid Redox Signal. 2014; 21: 819-834. doi: 10.1089/ars.2013.5661 PMID: 24738702
189. Alfaidy N, Chauvet S, Donadio-Andrei S, Salomon A, Saoudi Y, Richaud P, et al. Prion protein expression and functional importance in developmental angiogenesis: role in oxidative stress and copper homeostasis. Antioxid Redox Signal. 2013; 18: 400-411. doi: 10.1089/ars.2012.4637 PMID: 22861352
190. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996; 274: 995-998. PMID: 8875944
191. Bohlender J, Ganten D, Luft FC. Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol. 2000; 11: 2056-2061. PMID: 11053481
192. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008; 14: 855-862. doi: 10.1038/nm.1856 PMID: 18660815
193. Irani RA, Zhang Y, Zhou CC, Blackwell SC, Hicks MJ, Ramin SM, et al. Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension. 2010; 55: 1246-1253. doi: 10.1161/HYPERTENSIONAHA.110.150540 PMID: 20351341
194. Orshal JM, Khalil RA. Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension. 2004; 43: 434-444. PMID: 14707155
195. Zenclussen AC, Fest S, Joachim R, Klapp BF, Arck PC. Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol. 2004; 34: 377-387. PMID: 14768042
196. Li Z, Zhang Y, Ying Ma J, Kapoun AM, Shao Q, Kerr I, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 2007; 50: 686-692. PMID: 17724276
197. Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol. 2007; 196: 396 e391-397; discussion 396 e397. PMID: 17403433
198. Suzuki H, Ohkuchi A, Matsubara S, Takei Y, Murakami M, Shibuya M, et al. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice. Hypertension. 2009; 54: 1129-1135. doi: 10.1161/HYPERTENSIONAHA.109.134668 PMID: 19786649
199. Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, et al. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med. 2010; 14: 1857-1867. doi: 10.1111/j.1582-4934.2009.00820.x PMID: 19538465
200. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011; 108: 1451-1455. doi: 10.1073/pnas.1011293108 PMID: 21187414
201. Mateus J, Bytautiene E, Lu F, Tamayo EH, Betancourt A, Hankins GD, et al. Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1. Am J Physiol Heart Circ Physiol. 2011; 301: H1781-1787. doi: 10.1152/ajpheart.00373.2011 PMID: 21890691
202. Li F, Hagaman JR, Kim HS, Maeda N, Jennette JC, Faber JE, et al. eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype. J Am Soc Nephrol. 2012; 23: 652-660. doi: 10.1681/ASN.2011040369 PMID: 22282588
203. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet. 2001; 2: 538-548. PMID: 11433360
204. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, et al. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol. 2002; 250: 358-373. PMID: 12376109
205. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta. 2002; 23: 3-19. PMID: 11869088
206. Carter AM. Animal models of human placentation - a review. Placenta. 2007; 28 Suppl A: S41-47. PMID: 17196252
207. Cox B, Kotlyar M, Evangelou AI, Ignatchenko V, Ignatchenko A, Whiteley K, et al. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol Syst Biol. 2009; 5: 279. doi: 10.1038/msb.2009.37 PMID: 19536202
208. Krishnamurthy U, Szalai G, Neelavalli J, Shen Y, Chaiworapongsa T, Hernandez-Andrade E, et al. Quantitative T2 changes and susceptibility-weighted magnetic resonance imaging in murine pregnancy. Gynecol Obstet Invest. 2014; 78: 33-40. doi: 10.1159/000362552 PMID: 24861575
209. National Research Council of the National Academies: Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press. 2011.
210. Theiler K. The house mouse: atlas of embryonic development. New York: Springer-Verlag. 1989.
211. Turnbull DH. In utero ultrasound backscatter microscopy of early stage mouse embryos. Comput Med Imaging Graph. 1999; 23: 25-31. PMID: 10091865
212. Foster FS, Zhang MY, Zhou YQ, Liu G, Mehi J, Cherin E, et al. A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol. 2002; 28: 1165-1172. PMID: 12401387
213. Zhou YQ, Foster FS, Qu DW, Zhang M, Harasiewicz KA, Adamson SL. Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood. Physiol Genomics. 2002; 10: 113-126. PMID: 12181368
214. Brown SD, Zurakowski D, Rodriguez DP, Dunning PS, Hurley RJ, Taylor GA. Ultrasound diagnosis of mouse pregnancy and gestational staging. Comp Med. 2006; 56: 262-271. PMID: 16941953
215. Slevin JC, Byers L, Gertsenstein M, Qu D, Mu J, Sunn N, et al. High resolution ultrasound-guided microinjection for interventional studies of early embryonic and placental development in vivo in mice. BMC Dev Biol. 2006; 6: 10. PMID: 16504164
216. Pallares P, Gonzalez-Bulnes A. Non-invasive ultrasonographic characterization of phenotypic changes during embryo development in non-anesthetized mice of different genotypes. Theriogenology. 2008; 70: 44-52. doi: 10.1016/j.theriogenology.2008.02.012 PMID: 18407344
217. Pallares P, Fernandez-Valle ME, Gonzalez-Bulnes A. In vivo virtual histology of mouse embryogenesis by ultrasound biomicroscopy and magnetic resonance imaging. Reprod Fertil Dev. 2009; 21: 283-292. PMID: 19210919
218. Hernandez-Andrade E, Ahn H, Szalai G, Korzeniewski SJ, Wang B, King M, et al. Evaluation of uteroplacental and fetal hemodynamic parameters throughout gestation in pregnant mice using high-frequency ultrasound. Ultrasound Med Biol. 2014; 40: 351-360. doi: 10.1016/j.ultrasmedbio.2013.09.026 PMID: 24342911
219. Hoogstraten-Miller SL, Brown PA. Techniques in aseptic rodent surgery. Curr Protoc Immunol. 2008; Chapter 1: Unit 1 12 11-11 12-14.
220. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest. 1990; 63: 115-122. PMID: 1695694
221. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc. 2012; 7: 89-104. doi: 10.1038/nprot.2011.435 PMID: 22193302
222. Jose Pinheiro DB, Saikat DebRoy, Deepayan Sarkar, the R Development Core Team. nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1-108. 2013.
223. Buhimschi CS, Zhao G, Sora N, Madri JA, Buhimschi IA. Myometrial wound healing post-Cesarean delivery in the MRL/MpJ mouse model of uterine scarring. Am J Pathol. 2010; 177: 197-207. doi: 10.2353/ajpath.2010.091209 PMID: 20489145
224. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol. 2004; 286: H2408-2415. PMID: 14962829
225. Mills PA, Huetteman DA, Brockway BP, Zwiers LM, Gelsema AJ, Schwartz RS, et al. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol. 2000; 88: 1537-1544. PMID: 10797109
226. Kramer K, Voss HP, Grimbergen JA, Mills PA, Huetteman D, Zwiers L, et al. Telemetric monitoring of blood pressure in freely moving mice: a preliminary study. Lab Anim. 2000; 34: 272-280. PMID: 11037121
227. Van Vliet BN, Chafe LL, Antic V, Schnyder-Candrian S, Montani JP. Direct and indirect methods used to study arterial blood pressure. J Pharmacol Toxicol Methods. 2000; 44: 361-373. PMID: 11325579
228. Kramer K, Kinter LB. Evaluation and applications of radiotelemetry in small laboratory animals. Physiol Genomics. 2003; 13: 197-205. PMID: 12746464
229. Zhao X, Ho D, Gao S, Hong C, Vatner DE, Vatner SF. Arterial Pressure Monitoring in Mice. Curr Protoc Mouse Biol. 2011; 1: 105-122. PMID: 21686061
230. Carlson SH, Wyss JM. Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension. 2000; 35: E1-5. PMID: 10679520
231. Butz GM, Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics. 2001; 5: 89-97. PMID: 11242593
232. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arterioscler Thromb Vasc Biol. 2005; 25: 478-479. PMID: 15731487
233. Kaidi S, Brutel F, Van Deun F, Kramer K, Remie R, Dewe W, et al. Comparison of two methods (left carotid artery and abdominal aorta) for surgical implantation of radiotelemetry devices in CD-1 mice. Lab Anim. 2007; 41: 388-402. PMID: 17640466
234. HD-X11 Device Surgical Manual. St.Paul: Data Science International; 2011. pp. 32.
235. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010; 37: 239-253. doi: 10.1016/j.ogc.2010.02.013 PMID: 20685551
236. Siddiqui AH, Irani RA, Zhang Y, Dai Y, Blackwell SC, Ramin SM, et al. Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice. Am J Hypertens. 2011; 24: 606-612. doi: 10.1038/ajh.2010.247 PMID: 21183928
237. Falcao S, Stoyanova E, Cloutier G, Maurice RL, Gutkowska J, Lavoie JL. Mice overexpressing both human angiotensinogen and human renin as a model of superimposed preeclampsia on chronic hypertension. Hypertension. 2009; 54: 1401-1407. doi: 10.1161/HYPERTENSIONAHA.109.137356 PMID: 19822800
238. Singh J, Ahmed A, Girardi G. Role of complement component C1q in the onset of preeclampsia in mice. Hypertension. 2011; 58: 716-724. doi: 10.1161/HYPERTENSIONAHA.111.175919 PMID: 21859968
239. Kristal MB. Placentophagia: a biobehavioral enigma (or De gustibus non disputandum est). Neurosci Biobehav Rev. 1980; 4: 141-150. PMID: 6999389
240. Mu J, Slevin JC, Qu D, McCormick S, Adamson SL. In vivo quantification of embryonic and placental growth during gestation in mice using micro-ultrasound. Reprod Biol Endocrinol. 2008; 6: 34. doi: 10.1186/1477-7827-6-34 PMID: 18700008
241. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990; 5: 519-524. PMID: 2158038
242. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001; 26: 25-35. PMID: 11345501
243. Shibuya M. Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87: 167-178. PMID: 21558755
244. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 1992; 255: 989-991. PMID: 1312256
245. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995; 376: 66-70. PMID: 7596436
246. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem. 1996; 271: 5638-5646. PMID: 8621427
247. Shinkai A, Ito M, Anazawa H, Yamaguchi S, Shitara K, Shibuya M. Mapping of the sites involved in ligand association and dissociation at the extracellular domain of the kinase insert domain-containing receptor for vascular endothelial growth factor. J Biol Chem. 1998; 273: 31283-31288. PMID: 9813036
248. Tanaka K, Yamaguchi S, Sawano A, Shibuya M. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn J Cancer Res. 1997; 88: 867-876. PMID: 9369935
249. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993; 90: 10705-10709. PMID: 8248162
250. Thomas CP, Andrews JI, Liu KZ. Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta. Faseb J. 2007; 21: 3885-3895. PMID: 17615362
251. Kondo K, Hiratsuka S, Subbalakshmi E, Matsushime H, Shibuya M. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors. Gene. 1998; 208: 297-305. PMID: 9524283
252. He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol. 1999; 13: 537-545. PMID: 10194760
253. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun. 1996; 226: 324-328. PMID: 8806634
254. Thomas CP, Andrews JI, Raikwar NS, Kelley EA, Herse F, Dechend R, et al. A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab. 2009; 94: 2524-2530. doi: 10.1210/jc.2009-0017 PMID: 19336504
255. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001; 7: 205-210. PMID: 11160848
256. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003; 278: 12605-12608. PMID: 12538598
257. Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, Hankins GD, et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol. 2007; 197: 418 e411-415. PMID: 17904985
258. Byers BD, Betancourt A, Lu F, Hankins GD, Longo M, Saade GR, et al. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am J Obstet Gynecol. 2009; 200: 432 e431-437. doi: 10.1016/j.ajog.2009.01.044 PMID: 19318153
259. Bytautiene E, Lu F, Tamayo EH, Hankins GD, Longo M, Kublickiene K, et al. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol. 2010; 298: H189-193. doi: 10.1152/ajpheart.00792.2009 PMID: 19915174
260. Costantine MM, Tamayo E, Lu F, Bytautiene E, Longo M, Hankins GD, et al. Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol. 2010; 116: 114-120. doi: 10.1097/AOG.0b013e3181e10ebd PMID: 20567176
261. Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, Hankins GD, et al. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol. 2011; 205: 366 e361-365. doi: 10.1016/j.ajog.2011.06.083 PMID: 22083058
262. Xing A, Boileau P, Cauzac M, Challier JC, Girard J, Hauguel-de Mouzon S. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther. 2000; 11: 167-177. PMID: 10646648
263. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, et al. Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol. 2010; 177: 2950-2962. doi: 10.2353/ajpath.2010.090800 PMID: 20952590
264. Rajakumar A, Powers RW, Hubel CA, Shibata E, von Versen-Hoynck F, Plymire D, et al. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta. 2009; 30: 25-34. doi: 10.1016/j.placenta.2008.10.006 PMID: 19010535
265. Roberts JM. Objective evidence of endothelial dysfunction in preeclampsia. Am J Kidney Dis. 1999; 33: 992-997. PMID: 10328745
266. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002; 283: R29-45. PMID: 12069928
267. De P, Peng Q, Dmitry T, Li W, Yoder MC, March KL, et al. Expression of RAC2 in endothelial cells is required for the postnatal neovascular response. Exp Cell Res. 2009; 315: 248-263. PMID: 19123268
268. Conway BR, Rennie J, Bailey MA, Dunbar DR, Manning JR, Bellamy CO, et al. Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy. J Am Soc Nephrol. 2012; 23: 405-411. doi: 10.1681/ASN.2011060577 PMID: 22193383
269. Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol. 1994; 8: 443-468. PMID: 7924017
270. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007; 18: 2281-2284. PMID: 17634433
271. Kusinski LC, Stanley JL, Dilworth MR, Hirt CJ, Andersson IJ, Renshall LJ, et al. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. Am J Physiol Regul Integr Comp Physiol. 2012; 303: R86-93. doi: 10.1152/ajpregu.00600.2011 PMID: 22552791
272. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006; 194: 1034-1041. PMID: 16580293
273. Chia R, Achilli F, Festing MF, Fisher EM. The origins and uses of mouse outbred stocks. Nat Genet. 2005; 37: 1181-1186. PMID: 16254564
274. Aldinger KA, Sokoloff G, Rosenberg DM, Palmer AA, Millen KJ. Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS One. 2009; 4: e4729. doi: 10.1371/journal.pone.0004729 PMID: 19266100
275. Cao J, Gautier NM, Li MD. CD-1 mice Show Individual Differences in Nicotine Preference in a Modified Two-Bottle Oral Self-Administration Model. Front Psychiatry. 2012; 3: 28. doi: 10.3389/fpsyt.2012.00028 PMID: 22479254
276. Rigo J Jr, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy. 2000; 19: 163-172. PMID: 10877984
277. Paidas MJ, Ku DH, Langhoff-Roos J, Arkel YS. Inherited thrombophilias and adverse pregnancy outcome: screening and management. Semin Perinatol. 2005; 29: 150-163. PMID: 16114578
278. Girardi G. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation. Thromb Res. 2011; 127 Suppl 3: S43-46. doi: 10.1016/S0049-3848(11)70012-3 PMID: 21262438
279. Erez O, Hoppensteadt D, Romero R, Espinoza J, Goncalves L, Nien JK, et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med. 2007; 20: 661-667. PMID: 17701666
280. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006; 195: 40-49. PMID: 16813742
281. Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et al. An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. J Immunol. 2010; 185: 4420-4429. doi: 10.4049/jimmunol.0903215 PMID: 20810993